1. Everolimus reduces atherosclerosis and lipoprotein-associated phospholipase A2 (LP-PLA2) secretion in apolipoprotein e knockout mice. (August 2021) Authors: Potì, F.; Feuerborn, R.; Busnelli, M.; Dessena, M.; Nofer, J.-R. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gene expression profile reveals that ApoA-I levels modulate inflammation and lysosomal activity in murine advanced atherosclerosis. (August 2021) Authors: Busnelli, M.; Manzini, S.; Colombo, A.; Fontana, F.; Oleari, R.; Potì, F.; Castiglioni, S.; Bellosta, S.; Chiesa, G. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Interplay between S1P receptors and SR-BI in atherosclerosis relevant cells: New insight from transgenic animals. (August 2022) Authors: Dessena, M.; Simoni, M.; Nofer, J.-R.; Von Eckardstein, A.; Potì, F. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SKI-II, a sphingosine kinase 1 inhibitor, exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. Issue 1 (July 2015) Authors: Potì, F.; Ceglarek, U.; Burkhardt, R.; Simoni, M.; Nofer, J.R. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SKI-II, a sphingosine kinase 1 inhibitor, exacerbates atherosclerosis in low-density lipoprotein receptor-deficient (LDL-R-/-) mice on high cholesterol diet. Issue 1 (July 2015) Authors: Potì, F.; Ceglarek, U.; Burkhardt, R.; Simoni, M.; Nofer, J.R. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sphingosine 1-phosphate (S1P) receptor type 1 signaling induces an anti-atherogenic phenotype in macrophages and attenuates atherosclerosis in LDL-receptor-deficient mice. (December 2020) Authors: Potì, F.; Scalera, E.; Feuerborn, R.; Fischer, J.; Arndt, L.; Varga, G.; Pardali, E.; Seidl, M.; Liebisch, G.; Rosenbauer, F.; Renne, T.; Christoffersen, C.; Simoni, M.; Burkhardt, R.; Nofer, J.-R. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗